None listed
Conditions
Brief summary
Alcohol consumption is a foremost determinant for the prognosis of people with chronic viral hepatitis. There are vital benefits in providing assessment and brief intervention for reducing alcohol consumption and associated harms in people attending primary care settings. This randomised controlled trial aims to identify the effectiveness of an evidence based assessment and brief intervention in reducing or stopping harmful alcohol consumption in people with chronic viral hepatitis. Participants will be randomly allocated to three groups: Group1. (assessment and brochure), Group2. (assessment and brief intervention) or Group3. (routine care with no formalised intervention).
Interventions
Those in Intervention group will be assessed for alcohol use using the Audit-C and receive the Brief intervention using the 5As model from the nurses practitioner. The 10 minute intervention will be conducted as a part of the routine 30 minute appointment. The BI will comprise of Assessing people for their alcohol use, readiness to quit/reduce and level of alcohol dependence; Advising how they may stop drinking and the provision of evidence based written information; Agreeing on a realistic set of goals with the patient; Assisting with a plan to stop drinking and Arranging follow up with a specialist Alcohol and Drug service. The questionnaires for the intervention and control groups include Audit C, which assesses people for risky alcohol use Timeline Followback_Alcohol measures how much alcohol a person drinks over a 30 day period and the World Health Organisation Quality of Life (Brief) questionnaire. Demographics will also be collected.
Sponsors
Study design
Eligibility
Inclusion criteria
Participants who drink alcohol, are over 18 years of age, have Hepatitis B and/or C and are not currently on any alcohol management program are eligible to take part in the study.
Exclusion criteria
1. People who are currently undergoing interferon based treatment will be excluded from the study as symptoms from treatment may confound the health outcomes being measured in the project. 2. People who are assessed as being acutely mentally unwell or cognitvely impaired as the questionnaires have not been tested in this group. 3. People who do not speak or read english (the questionnaires have not been tested in this group)